Mitophagy, Inflammasomes and Their Interaction in Kidney Diseases: A Comprehensive Review of Experimental Studies

Yulin Wang1, Dongxu Song1, Lin Tang1

  • 1Department of Nephrology, Zhengzhou University First Affiliated Hospital, Zhengzhou, Henan, 450052, People's Republic of China.

Insights

Mitophagy and inflammasomes are key players in kidney disease. This review explores their interaction, highlighting their roles in mitochondrial quality control and inflammation within kidney pathologies.

Area of Science:

  • Cellular Biology
  • Immunology
  • Nephrology

Background:

  • Mitophagy is crucial for clearing damaged mitochondria, maintaining cellular health.
  • Inflammasomes are central to innate immunity and inflammatory responses, implicated in various diseases.
  • Kidney diseases often involve complex cellular damage and inflammatory processes.

Purpose of the Study:

  • To review the current understanding of mitophagy in the context of kidney diseases.
  • To examine the role of inflammasomes in kidney pathologies.
  • To elucidate the interplay between mitophagy and inflammasomes in kidney disease development and progression.

Main Methods:

  • Literature review of existing studies on mitophagy, inflammasomes, and kidney diseases.
  • Analysis of research focusing on the molecular mechanisms linking these pathways.
  • Synthesis of findings to provide a comprehensive overview.

Main Results:

  • Mitophagy dysfunction contributes to mitochondrial damage and cellular stress in kidney diseases.
  • Activated inflammasomes exacerbate kidney injury through inflammatory signaling.
  • Emerging evidence suggests a significant interaction between mitophagy and inflammasome pathways in kidney disease pathogenesis.

Conclusions:

  • Mitophagy and inflammasomes are critical regulators in kidney disease.
  • Targeting the mitophagy-inflammasome axis presents a potential therapeutic strategy for kidney disorders.
  • Further research is warranted to fully understand and exploit this interaction for clinical benefit.